Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

Xylem (XYL) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.99 per share a year ago. These figures are ...

Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax ...

Xylem plans job cuts across all of its business and functions as part of a restructuring plan to streamline its organization.

Shares of Xylem (NYSE:XYL) have seen a 20% pullback from the 2024 highs. This has in part been a response to high valuations from the get-go, a small correction in the full-year outlook alongside ...

Xylem Inc. is the global leader in water technology, offering comprehensive water solutions and has shown strong financial growth both organically and through strategic acquisitions like Evoqua ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

We wrap up our coverage of the markets and the week. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Researchers from HZB and Humboldt University Berlin have developed a CIGS-perovskite tandem solar cell that achieves a record ...

6 analysts have shared their evaluations of Xylem XYL during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their ...

Researchers at Oregon Health & Science University have uncovered how specialized cells surrounding small blood vessels, known as perivascular cells, contribute to blood vessel dysfunction in chronic ...